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Abstract
Background: Individuals in a malaria endemic community differ from one another. Many of these differences, such as 
heterogeneities in transmission or treatment-seeking behaviour, affect malaria epidemiology. The different kinds of 
heterogeneity are likely to be correlated. Little is known about their impact on the shape of age-prevalence and 
incidence curves. In this study, the effects of heterogeneity in transmission, treatment-seeking and risk of co-morbidity 
were simulated.
Methods: Simple patterns of heterogeneity were incorporated into a comprehensive individual-based model of 
Plasmodium falciparum malaria epidemiology. The different types of heterogeneity were systematically simulated 
individually, and in independent and co-varying pairs. The effects on age-curves for parasite prevalence, 
uncomplicated and severe episodes, direct and indirect mortality and first-line treatments and hospital admissions 
were examined.
Results: Different heterogeneities affected different outcomes with large effects reserved for outcomes which are 
directly affected by the action of the heterogeneity rather than via feedback on acquired immunity or fever thresholds. 
Transmission heterogeneity affected the age-curves for all outcomes. The peak parasite prevalence was reduced and 
all age-incidence curves crossed those of the reference scenario with a lower incidence in younger children and higher 
in older age-groups. Heterogeneity in the probability of seeking treatment reduced the peak incidence of first-line 
treatment and hospital admissions. Heterogeneity in co-morbidity risk showed little overall effect, but high and low 
values cancelled out for outcomes directly affected by its action. Independently varying pairs of heterogeneities 
produced additive effects. More variable results were produced for co-varying heterogeneities, with striking differences 
compared to independent pairs for some outcomes which were affected by both heterogeneities individually.
Conclusions: Different kinds of heterogeneity both have different effects and affect different outcomes. Patterns of co-
variation are also important. Alongside the absolute levels of different factors affecting age-curves, patterns of 
heterogeneity should be considered when parameterizing or validating models, interpreting data and inferring from 
one outcome to another.
Background
A myriad of differences between individuals in a commu-
nity affect the epidemiology of malaria. These differences
arise in roughly four ways: heterogeneity of transmission;
biological heterogeneity of the host in susceptibility and
response to malaria infection[1-4]; heterogeneity in host
behaviour, including quality of housing, use and knowl-
edge of protective measures such as insecticide-treated
nets (ITN) and treatment-seeking strategies; and hetero-
geneity in the risk of co-morbidity and malnutrition.
The different sources of heterogeneity are unlikely to be
independent. A factor, such as socio-economic status
(SES), may be associated with several different heteroge-
neities. SES can influence transmission intensity through
quality of housing, knowledge of protection measures
and use of ITNs [5-8]. Risks of co-morbidity and malnu-
trition may be associated with SES [9,10]. SES may influ-
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ence treatment-seeking behaviour [7]. Amongst those
caring for children, treatment-seeking [7,11-13] and
knowledge of danger signs [10,11] were worse in poorer
families. Such inequalities tend to persist over time [14].
Thus, covariance between different types of heterogene-
ity is plausible although the degree to which it occurs is
likely to vary between sites.
Differences among individuals can lead to important
patterns at the community level [15,16]. Different types of
heterogeneity may have implications for both the inter-
pretation of field data and for formulating and calibrating
models of the effects of interventions, or alternatively
may have little impact and could be safely ignored. Co-
variation may describe sub-groups within a population,
who perhaps respond differently to an intervention (for
example [17]) or who are reached neither by the health
system nor by any of several interventions.
Assessing the effects of different kinds of heterogeneity
using field datasets is not practical due to difficulties in
collecting the relevant data and isolating the effects of
each of the heterogeneities. Therefore, heterogeneity has
been investigated using mathematical models. There are
few examples of heterogeneity modelling studies specific
to malaria (for example [15,18-25]) and very few incorpo-
rating multiple types of heterogeneity [23,24]. One reason
may have been the models themselves. To study the
effects of multiple types of heterogeneity, a model must
be sufficiently comprehensive, dynamic to allow second-
ary effects, and be able to easily incorporate different
kinds of heterogeneity.
A recently published model of Plasmodium falciparum
malaria epidemiology [26] satisfies these criteria. It
includes processes for infection, parasitaemia, acquired
immunity, infectivity, morbidity and mortality and case-
management. It is dynamic, allowing feedback effects
such as the effects of high treatment coverage on trans-
mission intensity. It is also individual-based, which pro-
vides a flexible framework to conveniently incorporate
heterogeneity [27-29].
T h i s  m o d e l  i s  a d o p t e d  a s  a  b a s e  t o  i n v e s t i g a t e  t h e
effects of three different types of heterogeneity: transmis-
sion (including host behaviours such as bed net use and
housing), co-morbidity (as a trigger for severe malaria
and indirect mortality and reflecting the individual's gen-
eral health and nutrition) and treatment-seeking (the
chances of obtaining effective treatment). These hetero-
geneities are simulated singly, and in independent and co-
varying pairs. This paper focuses on the effects of hetero-
geneity on fundamental measures of the malaria burden,
age-prevalence and incidence curves. These curves are
known to vary by the severity of the outcome, degree of
seasonality and the overall levels of transmission intensity
(reviewed in [30]).
Methods
Base model
The stochastic model of malaria epidemiology has been
described in detail elsewhere [26]. Briefly, a simulated
population of humans are updated at each five-day time-
step via components representing new infections, para-
site densities, acquired immunity, uncomplicated and
severe episodes, direct and indirect malaria mortality,
and infectivity to mosquitoes. The course of parasite den-
sities over an infection are described by averaged empiri-
cal data [31]. Immunity to asexual parasites is derived
from a combination of cumulative exposure to both inoc-
ulations and parasite densities, and maternal immunity
[31]. The inclusion of acquired immunity allows us to
model potential effects of heterogeneity on immunity
through exposure being averted or increased. The proba-
bility of a clinical attack of malaria depends on the cur-
rent parasite density and a pyrogenic threshold [32]. The
pyrogenic threshold responds dynamically to recent para-
site load, increasing or saturating through exposure to
parasites and decaying with time, and thus is individual-
and time-specific. Severe malaria can arise in two ways,
either as a result of overwhelming parasite density or
through uncomplicated malaria with concurrent non-
malaria co-morbidity [33]. Treatment of malaria is based
on the case management model of Tediosi and colleagues
[34] which involves implementing case management
trees for severe cases, and uncomplicated cases with and
without recent history of treatment. In the current simu-
lations, we assumed first-line treatment of uncomplicated
e p i s o d e s  t o  b e  a n  e f f e c t i v e  s h o r t - a c t i n g  d r u g  s u c h  a s
artemisinin-combination therapy (ACT) with an average
probability of treatment at any one five-day time step of
20%. This value is higher than previously used [34-37]; it
was raised arbitrarily to allow the effects of treatment
heterogeneity to show. The treatment probability for
severe cases warranting hospital admission was 48% [33].
Mortality in this model can be either direct (following
s e v e r e  m a l a r i a )  o r  i n d i r e c t  ( u n c o m p l i c a t e d  m a l a r i a  i n
conjunction with co-morbidity, or during the neonatal
period as a result of maternal infection) [33]. This co-
morbidity is simulated as occurring with an age-depen-
dent probability described by a hyperbolic function [33].
The parameter values for the base model were esti-
mated by fitting to data from a total of 61 malaria field
studies of various different aspects of malaria epidemiol-
ogy [38], and are reported elsewhere [37].
Types of heterogeneity
Some individual differences are inherent to the base
model and arise due to host age and an individual's pro-
pensity for high parasite densities [31]. In addition, sto-
chasticity occurs throughout the model.Ross and Smith Malaria Journal 2010, 9:132
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We extended the base model by introducing an addi-
tional three types of heterogeneity: (i) transmission, (ii)
co-morbidity and (iii) treatment-seeking probability. This
study does not consider heterogeneity in the biological
response of the host (except for the host dependent het-
erogeneity in parasite densities incorporated into the
base model). The model processes are shown in Figure 1.
Each simulated individual is assigned a status for each of
the three kinds of heterogeneity at birth, which they carry
throughout their life. The structure of the heterogeneities
is that 50% of the population are assigned to each of the
high and low status categories, with baseline values mul-
tiplied by either 1.8 or 0.2. Hence, when assuming hetero-
geneity in transmission, the age-adjusted entomological
inoculation rate (EIR) for individual i at time t takes the
value: EL(i,t) = 0.2Ea(i,t) for the low exposure half of the
population, where Ea(i, t) is the age-adjusted EIR in the
base model, and EH(i,t) = 1.8Ea(i,t) in the high exposure
half of the population. Similarly, in models of treatment
heterogeneity, the probability that either an uncompli-
cated or severe attack is treated during any one simula-
tion step takes a value of 1.8 (or 0.2) times that in the base
model; in models of heterogeneous co-morbidity, two
age-dependent probabilities are multiplied by 1.8 (or 0.2),
the probability that a clinical attack becomes severe due
to co-morbidity in any one five-day time step and the
probability that, following a malaria episode which weak-
ens the host, a non-malaria illness occurs leading to an
indirect death.
In simulations of co-varying heterogeneities, the same
50% of the population are at greater risk on each of the
three dimensions. Thus low access to treatment is paired
with high numbers of infective bites and high risk of co-
morbidity.
The present analyses make use of estimates of the
remaining parameters in the model derived assuming no
heterogeneity in the three variables that are the subject of
this study [38]. Results of re-estimation of these parame-
ters conditional on different assumptions about heteroge-
neity will be reported elsewhere.
Scenarios simulated
A reference scenario was defined using the input values
in Table 1. This study does not report simulations of
interventions other than case-management. The three
types of heterogeneity were added to the base model and
their effects systematically simulated singly, in indepen-
dent pairs, and in co-varying pairs. The outcomes were
parasite prevalence, uncomplicated and severe clinical
episodes, direct and indirect mortality, first-line treat-
ments and hospital admissions. The age-prevalence and
incidence curves were described using the age at, and
Table 1: Reference scenario characteristics.
Input Value
Transmission intensity 21 infected bites per year per 
adult †
Seasonality Perennial with seasonal 
peaks (Namawala, Tanzania 
[39])†
Treatment-seeking 0.2 per fever-5 day interval ‡
Treatment drug ACT (clears all infections)†
Demographic age-
distribution
Ifakara, Tanzania [53]†
† These values were used in previous simulations [35-37]
‡ This value is higher than previous simulations to allow the effect 
of treatment heterogeneity to show clearly
Figure 1 Model processes and the types of heterogeneity. Blue ar-
row: Transmission heterogeneity affects an individual's availability to 
mosquitoes which is represented in the base model as an age-depen-
dent function. Red arrows: Heterogeneity in the risk of co-morbidity af-
fects the probability of a non-malaria illness or poor nutritional status 
which, in conjunction with an acute malaria episode, leads to either se-
vere malaria or to an indirect death. In the base model, the risks of 
these two sets of co-morbidity are represented by two age-dependent 
functions. Green boxes: Treatment-seeking heterogeneity affects the 
probabilities that effective treatment is sought for either a fever or for 
a severe episode per five day time step. In the base model, these prob-
abilities are represented by two constants.
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height of, the peak. To investigate the effect of transmis-
sion intensity on the effects of heterogeneity, this set of
simulations was repeated for settings with 1, 6 and 200
infectious bites per person per year. The seasonality in all
scenarios followed that of Namawala, Tanzania [39]
(Table 1). Average annual transmission levels were held
constant so that effects were not simply due to changes in
transmission.
Results
The effect of single heterogeneities
Transmission
Heterogeneity in transmission affected all of the out-
comes (Additional File 1: Table S1). The predicted preva-
lence of parasitaemia was reduced (Figure 2a). For the
other outcomes, the incidence rates were reduced in
younger age groups compared to the reference scenario
and increased for older ages (Figure 2b).
Co-morbidity risk
There was no apparent overall effect of heterogeneity in
co-morbidity risk on the age-curves. However, taken sep-
arately, low and high co-morbidity levels did show large
effects on some outcomes suggesting that the combined
effects cancel out in the scenario with heterogeneity (Fig-
ure 3). The outcomes affected were those directly
affected by the action of co-morbidity risk: severe epi-
sodes (and hence direct mortality), hospital admissions,
and indirect mortality. Co-morbidity does not influence
acquired immunity in the model and so there were no
feedback effects.
Probability of seeking treatment
The strongest effect of heterogeneity in treatment-seek-
ing behaviour was a reduction in the incidence of both
first-line treatments and hospital admissions (Figure 4).
Taken separately, low and high levels of treatment-seek-
ing affected all outcomes: low levels lead to increased
prevalence and increased incidence of episodes and
deaths. When combined in the scenario with heterogene-
ity in treatment-seeking levels however, the overall effect
Figure 2 Predicted effect of heterogeneity in transmission on (a) prevalence and (b) incidence of uncomplicated episodes. Black circles = 
reference scenario defined in Table 1. Red squares = with heterogeneous transmission.
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Figure 3 Predicted effect of co-morbidity risk on indirect malaria 
mortality. Black circles = reference scenario as defined in Table 1; blue 
triangles = heterogeneity in co-morbidity risk; dark blue squares = high 
co-morbidity risk; light blue diamonds = low co-morbidity risk.
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was limited, with slight increases in the peak for parasite
prevalence and uncomplicated episodes (Additional File
1: Table S1).
In general, the strongest effects of the single heteroge-
neities were reserved for outcomes directly affected by
the action of the heterogeneity. Feedback via acquired
immunity produced more modest effects. For some out-
comes, the effects of high and low values of the heteroge-
neity appeared to cancel out at the community level.
Independent and co-varying pairs of heterogeneities
The results suggest that the two independent types of
heterogeneities together produce additive effects on the
age-curves (Additional File 2: Table S2).
The results for sources of heterogeneity which co-vary
were more variable. Changes in comparison to the inde-
pendently varying case occurred only if the outcome
measure was affected by both kinds of heterogeneity indi-
vidually, either apparent or masked by high and low val-
ues cancelling out. Changes were observed in outcomes
which were directly affected by the action of the hetero-
geneity. Striking differences compared to independent
heterogeneities were produced for hospital admissions
and direct mortality (co-morbidity and treatment-seek-
ing: Figure 5) and first-line and hospital admissions
(transmission and treatment-seeking: Figure 6). More
modest changes were produced for other outcomes
(Additional File 2: Table S2).
There were no changes for outcomes which were not
affected by both heterogeneities individually. Prevalence,
uncomplicated episodes and first-line treatments were
unaffected by heterogeneity in co-morbidity and no
changes were observed for the pairs co-morbidity and
treatment-seeking, and co-morbidity and transmission.
There were also no apparent changes to the age-curves
for prevalence, uncomplicated and severe episodes, and
direct and indirect mortality (transmission and treat-
ment-seeking). Although both types of heterogeneity
Figure 5 Predicted incidence of hospital admissions with hetero-
geneity in risk of co-morbidity and probability of seeking treat-
ment. Hollow black circles = reference (Table 1); pink triangles = 
heterogeneity in probability of seeking treatment; blue inverted trian-
gles = heterogeneity in risk of co-morbidity; green diamonds = hetero-
geneity in both treatment-seeking and co-morbidity (independent); 
black solid circles = co-varying heterogeneity in both co-morbidity and 
treatment-seeking.
age in years
h
o
s
p
i
t
a
l
 
a
d
m
i
s
s
i
o
n
s
 
p
e
r
 
p
e
r
s
o
n
-
y
e
a
r
0.5 1 2 5 10 20 50
0.00
0.01
0.02
0.03
0.04
0.05
Figure 6 Predicted effect of heterogeneity in transmission and 
treatment-seeking on the incidence of first-line treatments. Hol-
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seeking and transmission (independent); black solid circles = co-vary-
ing heterogeneity in both transmission and treatment-seeking.
age in years
t
r
e
a
t
e
d
 
e
p
i
s
o
d
e
s
 
p
e
r
 
p
e
r
s
o
n
-
y
e
a
r
0.5 1 2 5 10 20 50
0.0
0.5
1.0
1.5
Figure 4 Predicted effect of heterogeneity in the probability of 
seeking treatment on the incidence of first-line treatments. Black 
circles = reference scenario as defined in Table 1; pink triangles = with 
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either affected these outcomes or masked effects at high
and low levels, the effect of treatment is via dynamic
feedback on acquired immunity. Outcomes which are not
directly influenced by the action of the heterogeneities
are less affected in our simulations.
The effect of heterogeneity in all three variables was
simulated for completeness (Additional File 1: Table S1),
however interpreting the results is difficult. In general,
age-curves for outcomes affected by only two of the het-
erogeneities were similar to those produced by the pair of
heterogeneities. Where all three had individual effects,
the independent and co-varying triple heterogeneities
could have effects which were very different to each
other.
The effect of heterogeneity for different transmission 
intensities
These simulations were repeated for different transmis-
sion intensities (EIR 1, 6 and 200) keeping the same sea-
sonal pattern. The age-curves shift due to the effects of
transmission intensity, but the direction and strength of
the impact of the different types and combinations of het-
erogeneity were similar to those of the reference trans-
mission of 21 infectious bites per person per year.
Discussion
This study describes the simulated effects of heterogene-
ity in transmission intensity, co-morbidity risk and treat-
ment-seeking behaviour on the age-curves of a range of
measures of the burden of malaria. Although this study is
specific to malaria, our findings add more generally to
studies of infectious diseases indicating that it is not only
the absolute level of a variable, but also the presence of
heterogeneity [15,22,25,40] and co-variation [23,28],
which can produce important patterns at the community
level.
The results show that the different types of heterogene-
ity have effects on different outcomes with large effects
reserved for outcomes directly affected by the action of
the heterogeneity, rather than dynamic feedback via
acquired immunity. Transmission heterogeneity affected
the age-curves for all outcomes. The peak parasite preva-
lence was reduced and all age-incidence curves crossed
those of the reference scenario with a lower incidence in
younger children and higher in older age-groups. Hetero-
geneity in the probability of seeking treatment reduced
the peak incidence of first-line treatment and hospital
admissions. Heterogeneity in co-morbidity risk showed
little overall effect, but high and low values cancelled out
for outcomes influenced by its action. Independently
varying pairs of heterogeneities produced additive
effects. More variable results were produced for co-vary-
ing pairs, with striking differences compared to indepen-
d e n t  p a i r s  f o r  s o m e  o u t c o m e s  w h i c h  w e r e  a f f e c t e d  b y
both heterogeneities individually.
These findings have implications for both the interpre-
tation of age-curves and their use in analysis and model-
ling. In pointing to where the different types of
heterogeneity change the shape of the age-curves, this
study also indicates where there is no need for concern.
Since the greatest effects of single heterogeneities were
reserved for outcomes directly affected or subsequent to
their action, only modest effects would be expected for
outcomes less directly linked unless transmission inten-
sity is affected. Outcomes which were unaffected by sin-
gle heterogeneities do not change substantially when
there are concurrent heterogenous variables, either inde-
pendent or co-varying.
The results illustrate the effect of heterogeneity on the
ability to infer from one outcome to another. The utility
of passive case detection to estimate the burden of clini-
cal disease depends on assumptions about the underlying
distribution of treatment-seeking behaviour. Similarly,
the use of clinical episodes to infer effects on mortality
depends on heterogeneity in the risk of co-morbidity and
treatment-seeking. Patterns of heterogeneity are also
important when estimating transmission from prevalence
or clinical data.
A logical consequence of the findings is that estimating
parameter values by fitting a model to data from a single
field site falsely assuming either homogeneity or indepen-
dently varying variables is liable to produce incorrect val-
ues, as found elsewhere [15,23,25].
This study has several limitations. The adopted repre-
sentation of the patterns of heterogeneity was very crude.
Whilst the strength of the impact will differ, the conclu-
sions are not dependent on the values chosen for the high
and low risk groups, on the distribution of individuals
between groups or on whether there is a gradual increase
in risk across individuals as long as the overall values are
equal in the heterogeneity and comparison scenarios.
Thus, although the scenarios do not exhibit realistic pat-
terns, the findings nevertheless provide insights on the
substantive effects of different types of heterogeneity.
Likewise, there was no intention to realistically portray
SES. There are complex pathways between poverty, eco-
nomic activity, health-care seeking and malaria [7,13,41].
The scope of this study is limited to the incorporation of
simple heterogeneity in three variables which are plausi-
bly related to SES into a model of malaria epidemiology. It
was also assumed that the individual's relative levels for
transmission, co-morbidity risk and treatment-seeking
are constant throughout their life. This simplification
ignores the impact of malaria on poverty [13,42] and
mobility [43]. More sophisticated simulations may
address the need to disaggregate SES [44] and identifyRoss and Smith Malaria Journal 2010, 9:132
http://www.malariajournal.com/content/9/1/132
Page 7 of 9
interventions of particular benefit to the poor (such as
[45]).
Assumptions were made about the likely direction of
co-variation, matching high transmission to a high risk of
co-morbidity and low probability of seeking treatment. In
different settings and ecotypes, these directions may be
reversed. Individuals are assumed to be distributed spa-
tially at random. Spatial patterns could be better incorpo-
rated by grouping individuals into households.
Objective criteria are lacking for determining whether
two age-curves differ. However, the patterns observed
were clear-cut. In this study, heterogeneity in transmis-
sion had the strongest effects on the age-curves. It is
plausible that this would also be the case in many real set-
tings. However, this study does not use use a realistic pat-
terns and degrees of heterogeneity, and so conclusions
cannot be drawn about the relative importance of the
three heterogeneities on the shape of the age-curves.
The average annual level of transmission was fixed to
remain constant so that the effects observed were solely
due to heterogeneity when compared to the reference
scenario. However, heterogeneity may also alter the abso-
lute level of transmission intensity via dynamic feedback
to the infectious reservoir.
The base model used is comprehensive and individual-
based providing a flexible framework for unravelling the
effects of different heterogeneities. Limitations of the
model components are discussed elsewhere [26,31-33,46-
49]. Some assumptions are especially relevant to this
study. Non-malaria co-morbidity is assumed to prompt
an acute episode to lead to either a severe episode or an
indirect death, and the risk of co-morbidity is assumed to
be age-dependent. This is reflected in the age-curves for
both the reference scenario and the inclusion of heteroge-
neity in co-morbidity risk. The base model assumes con-
stant probabilities for seeking treatment within a five-day
period for all individuals with either acute or severe epi-
sodes. However, treatment-seeking may be age-depen-
dent, due to differences in the recognition of fevers or
perceived need for treatment in adults, children and
infants and also to the tendency for different symptoms
to manifest at different ages such as severe malarial anae-
mia in young children [50]. The five-day time step con-
strains the model components for both treatment-
seeking and case-management to be very simple. The
time steps are currently being shortened to one day and a
more sophisticated case-management model is in devel-
opment.
Effects of heterogeneity on outcomes other than age-
curves were beyond the scope of this paper. Heterogene-
ity is likely to have important effects on receptivity and
elimination [15,19-21], on individual differences and
equality, and on the impact of different interventions [22-
24]. Some interventions may lessen the differences
between individuals in a population, but the effects of
reducing heterogeneity are not yet known. In addition to
f u r t h e r  s i m u l a t i o n  s t u d i e s ,  f u t u r e  w o r k  s h o u l d  a l s o
extend the analysis of available field data to describe the
pattern of heterogeneity in different settings. Innovative
methods are needed to estimate sources of heterogeneity
that are difficult to measure, such as for micro-transmis-
sion [25,51,52], and multivariate analysis estimating the
degree and patterns of co-variation would enable more
realistic scenarios to be considered.
Conclusions
Heterogeneity is not a single entity: different types and
combinations of heterogeneity lead to different effects.
Interpretation and use of age-prevalence or age-incidence
curves should involve consideration of the nature and
extent of different heterogeneities in the populations
being analysed.
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